NCT07295587

Brief Summary

The main objective of this study is to evaluate the impact of primary headaches using data previously collected in a healthcare program conducted by Libbs with its employees. The study aims to identify the main types of headaches, assess their impact on work and quality of life, describe treatment modalities and healthcare services used, and analyze possible correlations between job position or sector and the occurrence of headaches, as well as their impact on productivity. This retrospective observational study analyzes secondary data collected from Libbs employees during a healthcare program designed to understand the impact of migraine on work productivity and daily activities. Data were obtained through validated questionnaires made available via an app. As this study involves the analysis of previously collected data, it does not provide direct benefits to participants. However, it contributes to a better understanding of migraine symptoms among Libbs employees, supports awareness of the risks of self-medication, and highlights the effects of headaches on daily routines and productivity. No therapeutic intervention is proposed in this study. Decisions regarding diagnosis, interventions, and treatments were made exclusively by the Dr. Cefaleia app team at the time of data collection, without any interference related to the development of this research. The HIT-6 score and the four WPAI outcomes will be analyzed: absenteeism (lost work time), presenteeism (impairment while working), overall work productivity loss (absenteeism plus presenteeism), and impairment in activities outside of work. This study provides an opportunity to expand the understanding of the relationship between working conditions, headaches, health, and productivity. The analysis may help identify epidemiological patterns and occupational or social risk factors associated with headaches, supporting future preventive strategies and workplace health initiatives aimed at improving quality of life and productivity.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,342

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 19, 2025

Completed
13 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

1 month

First QC Date

December 4, 2025

Last Update Submit

December 16, 2025

Conditions

Keywords

MigraineheadacheDr.CefaleiaLibbs

Outcome Measures

Primary Outcomes (1)

  • Assessment of the impact of migraine on Libbs employees

    Given the observational nature of this study, the sample size for the study will not be calculated based on statistical considerations. Probabilistic and non-random sampling will be considered with the available data. The primary database contains data collected from 1,342 employees, out of a total of 2,957 employees at the company at the time. This is an observational, retrospective, descriptive study based on an anonymized secondary database, originating from data collected in a welfare program carried out by Libbs with its employees, who will response time on the form for entering data such as: age, gender, education, role, department, affiliate, presence of headache (yes or no)

    1 month

Study Arms (1)

Libbs´employees

All volunteer employees of Libbs Pharmaceuticals residing in all Brazilian regions will participate in this research. An online questionnaire will be applied to assess research subjects understanding of migraine and health habits.

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Libbs´employees

You may qualify if:

  • This analysis will include data from all employees who participated in this assistance program and made their data available in the Dr. Cefaleia app.

You may not qualify if:

  • Data from participants whose questionnaires were not completed in full will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Libbs Farmacêutica LTDA.

São Paulo, São Paulo, 05036040, Brazil

Location

MeSH Terms

Conditions

Migraine DisordersHeadache

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Renan B Domingues

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2025

First Posted

December 19, 2025

Study Start

January 1, 2026

Primary Completion

February 1, 2026

Study Completion

February 1, 2026

Last Updated

December 19, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Because the data is anonymized.

Locations